2024 CERSI Scientific Symposium
475 Via Ortega 3rd Floor, Stanford, CA 94305
Overview
The UCSF-Stanford Center of Excellence in Regulatory Science and Innovation (UCSF-Stanford CERSI), University of Maryland CERSI (M-CERSI), Johns Hopkins University CERSI (JHU-CERSI), Yale-Mayo CERSI (Yale University, Mayo Clinic), and Research Triangle CERSI (University of North Carolina, Chapel Hill and Duke University) are pleased to present the inaugural CERSI Scientific Symposium. This event will feature exciting presentations by expert investigators from all CERSI sites on their cutting-edge, collaborative regulatory science research projects with FDA investigators.
Video Recording of the meeting.
Agenda
Time | Title |
8:30 - 9:00 am | Sign-In |
9:00 - 9:05 am |
Welcome
|
9:05 - 9:10 am |
Opening Remarks
|
9:10 - 9:20 am |
Overview of CERSI Program
|
Session 1 - Advanced Manufacturing and Increasing Data Capacity |
|
9:20 - 9:25 am |
Session Overview |
9:25 - 9:40 am |
Water Proton Nuclear Magnetic Resonance to Characterize Gene and Cell Therapy Products |
9:40 - 9:55 am | Persistent In-Line Sensor for Real-World Loading Characterization of Osseointegrated Implants and Prosthetic Devices Courtney Moran, CP, MS | Project Manager, Johns Hopkins University Applied Physics Laboratory |
9:55 - 10:10 am |
Optimizing and Assessing Safety of Homology Directed Repair Based Genome Editing |
10:10 - 10:20 am | Session Panel Q&A |
10:20 - 10:30 am | Break |
Session 2 - Clinical Outcome Assessment Surveys and Tools |
|
10:30 - 10:35 am |
Session Overview |
10:35 - 10:50 am |
Physical Function Assessments in Cancer Clinical Trials |
10:50 - 11:05 am |
Clinical Outcome Assessments (COAs) and Patient-Centricity |
11:05 - 11:20 am |
Imaging as Intervention: Approaches to Estimating the Real-World Effectiveness of Novel Molecular Imaging Tools in Prostate Cancer |
11:20 - 11:30 am | Session Panel Q&A |
Session 3 - Approaches to Incorporate Patient and Consumer Input |
|
11:30 - 11:35 am |
Session Overview |
11:35 - 11:50 am |
Techniques to Specify How Consumers Respond to Tobacco Marketing and FDA Educational Messaging |
11:50 - 12:05 pm |
Using Stated Preference Methods to Incorporate Patient Input for Benefit-Risk Decision-Making |
12:05 - 12:20 pm |
Comparing Methods for Identifying Patients’ Preferences at Decision Making |
12:20 - 12:30 pm | Session Panel Q&A |
12:30 - 12:50 pm |
Pick Up Boxed Lunches |
Session 4 - Methods to Assess Viability of Real World Data |
|
12:50 - 12:55 pm |
Session Overview |
12:55 - 1:10 pm |
Understanding the Use of Existing Real-World Data for Medical Product Evaluation |
1:10 - 1:25 pm |
Utilizing UNC Clinical Data Warehouse for Dose-Response Relationships of Targeted Therapies in RWPs |
1:25 - 1:40 pm |
Epidemiologic Challenges to Using Real-World Large Claims Data to Study Opioid Use Disorder Treatment Cascades and Trajectories |
1:40 - 1:50 pm | Session Panel Q&A |
1:50 - 1:55 pm |
Closing Remarks |
1:55 - 3:00 pm |
Poster Reception |